NEWSAR

Multi-perspective news intelligence

T

teplizumab

Topic Health

Teplizumab, sold under the brand name Tzield among others, is an anti-CD3 humanized monoclonal antibody and the first approved treatment indicated to delay the onset of stage 3 type 1 diabetes in people living with stage 2 type 1 diabetes.

Total Coverage:0 articles

Last 7 Days:0

View on Wikipedia →

Coverage Timeline

Drug that delays onset of type 1 diabetes approved in England and Wales

Drug that delays onset of type 1 diabetes approved in England and Wales

Related Entities

topic•1 mentions

location•1 mentions

location•1 mentions

location•1 mentions

organization•1 mentions

type 1 diabetes

topic•1 mentions

National Institute for Health and Care Excellence

organization•1 mentions

organization•1 mentions